annb0t
Top 20
FLUAD® is now preferentially recommended by the National Advisory Committee on Immunization for adults 65 years of age and older.
MONTREAL, Dec. 21, 2023 /CNW/ -Â CSL Seqirus commends the National Advisory Committee on Immunization's (NACI's) recent recommendation for adults 65 years of age and older to preferentially receive an enhanced influenza vaccine, which includes adjuvanted, high-dose and recombinant vaccines. This recommendation is based on data from studies that show that all app...
>>> Read more: CSL Seqirus Commends the National Advisory Committee on Immunization for Preferential Recommendation of Enhanced Influenza Vaccines for Adults 65 and Older
MONTREAL, Dec. 21, 2023 /CNW/ -Â CSL Seqirus commends the National Advisory Committee on Immunization's (NACI's) recent recommendation for adults 65 years of age and older to preferentially receive an enhanced influenza vaccine, which includes adjuvanted, high-dose and recombinant vaccines. This recommendation is based on data from studies that show that all app...
>>> Read more: CSL Seqirus Commends the National Advisory Committee on Immunization for Preferential Recommendation of Enhanced Influenza Vaccines for Adults 65 and Older
